**UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549**

---

**FORM 10-Q**

---

(MARK ONE)

**[X]      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
             SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended **September 30, 2000** or**

**[  ]       TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934**

**FOR THE TRANSITION PERIOD FROM ___________ TO  _____________**

**Commission file number 0-12254**

**SCIENTIFIC TECHNOLOGIES INCORPORATED**
(Exact name of registrant as specified in its charter)



|**Oregon**                                                     | **77-0170363**                         
|-------------------------------------------------------------- | ---------------------------------------
|(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification Number)

**6550 Dumbarton CircleFremont, CA     94555**(Address of principal executive offices including zip code)

**(510) 608-3400**(Registrant's telephone number, including area code)







Check whether the issuer (1) has filed all reports required
to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant
was required to file reports), and (2) has been subject to such filing
requirements for the past 90 days.    YES [X] NO [   ],

Common stock outstanding as of October 31, 2000 was 9,637,287 shares.







**SCIENTIFIC TECHNOLOGIES INCORPORATED
                           Report On Form 10-Q For The
                           Quarter Ended September 30, 2000
                                     INDEX**



|**PART I.   Financial Information**                                                                                   | **Page No.**
|--------------------------------------------------------------------------------------------------------------------- | ------------
|                                                                                                                      |             
|Item 1.   Financial Statements
                  (unaudited):                                                         |             
|                                                                                                                      |             
|Consolidated Balance Sheets as of
          
     September 30, 2000 and December 31, 1999                            | **          
|                                                                                                                      |             
|Consolidated Statements of Operations for the
          
    Three and Nine Months ended September 30, 2000 and 1999  | **          
|                                                                                                                      |             
|Consolidated Statements of Cash Flows for the
          
    Nine Months ended September 30, 2000 and 1999            | **          
|                                                                                                                      |             
|Notes to Consolidated Financial Statements                                                                            | **          
|                                                                                                                      |             
|Item 2.   Management's Discussion and Analysis of Financial
                      Condition and Results of Operations | **          
|                                                                                                                      |             
|**PART II.  Other Information**                                                                                       |             
|                                                                                                                      |             
|Item 1.   legal Proceedings                                                                                           | **          
|                                                                                                                      |             
|Item 2: Changes in Securities and Use of Proceeds                                                                     | **          
|                                                                                                                      |             
|Item 3: Defaults Upon Senior Securities                                                                               | **          
|                                                                                                                      |             
|Item 4: Submission of Matters to a Vote of Security Holders                                                           | **          
|                                                                                                                      |             
|Item 5: Other Information                                                                                             | **          
|                                                                                                                      |             
|Item 6.   Exhibits and Reports on Form 8-K                                                                            | **          
|                                                                                                                      |             
|**Signatures**                                                                                                        | **          

---

**PART I -- FINANCIAL INFORMATION

Item 1. Financial Statements**

---

**SCIENTIFIC TECHNOLOGIES INCORPORATED

                           CONSOLIDATED BALANCE SHEET

                           (Unaudited, in thousands)**

`September 30, December 31,
                                                        2000          1999
                                                    -----------   -----------
                     Assets
Current assets:
    Cash and cash equivalents                      $       184   $     3,362
    Short-term investments                               3,780         5,209
    Accounts and notes receivable, net                   9,445         8,822
    Inventories (Note 1)                                 8,586         8,414
    Deferred income taxes                                  852           852
    Other assets                                           692           740
                                                    -----------   -----------
       Total current assets                             23,539        27,399
Intangible assets                                        8,868         2,271
Property and equipment, net                              3,571         2,866
                                                    -----------   -----------
       Total assets                                $    35,978   $    32,536
                                                    ===========   ===========

              Liabilities and Stockholders' Equity
Current liabilities:
    Trade accounts payable                         $     1,613   $     2,695
    Payable to Parent                                      391            --
    Accrued expenses                                     3,147         1,992
                                                    -----------   -----------
       Total current liabilities                         5,151         4,687
                                                    -----------   -----------


Stockholders' equity
    Common stock: shares authorized 20,000,
      issued and outstanding: 9,630
      ($.001 par value)                                     10            10
    Capital in excess of par value                       5,527         5,509
    Retained earnings                                   25,290        22,330
                                                    -----------   -----------
       Total stockholders' equity                       30,827        27,849
                                                    -----------   -----------
       Total liabilities and stockholders' equity  $    35,978   $    32,536
                                                    ===========   ===========`

The accompanying notes are an integral part of these financial statements.

---

**SCIENTIFIC TECHNOLOGIES INCORPORATED

                       CONSOLIDATED STATEMENT OF OPERATIONS

               (Unaudited, in thousands, except per share amounts)**

`Three Months Ended       Nine Months Ended
                                         September 30,           September 30,
                                   ----------------------  ----------------------
                                       2000        1999        2000        1999
                                   ----------  ----------  ----------  ----------
Sales                             $   14,992  $   12,804  $   43,691  $   36,378
Cost of goods sold                     7,494       6,410      21,131      18,168
                                   ----------  ----------  ----------  ----------
  Gross profit                         7,498       6,394      22,560      18,210
                                   ----------  ----------  ----------  ----------
Operating expenses
  Selling, general and
    administrative                     3,776       3,231      11,682       9,545
  Research and development             1,192       1,169       3,920       3,465
                                   ----------  ----------  ----------  ----------
   Total operating expenses            4,968       4,400      15,602      13,010
                                   ----------  ----------  ----------  ----------
   Income from operations              2,530       1,994       6,958       5,200

Interest and other income, net            57         111         153         361
                                   ----------  ----------  ----------  ----------
   Income before income taxes          2,587       2,105       7,111       5,561

Provision for income taxes               983         800       2,702       2,113
                                   ----------  ----------  ----------  ----------
        Net income                $    1,604  $    1,305  $    4,409  $    3,448
                                   ==========  ==========  ==========  ==========

Net income per common share
  (Note 2)
    Basic                         $     0.17  $     0.13  $     0.46  $     0.36
                                   ==========  ==========  ==========  ==========
    Diluted                       $     0.16  $     0.13  $     0.46  $     0.36
                                   ==========  ==========  ==========  ==========
Shares used to compute net
  income per common share
  (Note 2)
    Basic                              9,637       9,667       9,640       9,652
                                   ==========  ==========  ==========  ==========
    Diluted                            9,733       9,692       9,667       9,678
                                   ==========  ==========  ==========  ==========`

The accompanying notes are an integral part of these financial statements.

---

**SCIENTIFIC TECHNOLOGIES INCORPORATED

                 CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

                           (Unaudited, in thousands)**

`Nine Months Ended
                                                          September 30,
                                                     ------------------------
                                                         2000         1999
                                                     -----------  -----------
Cash flows from operating activities:
  Net income                                        $     4,409  $     3,448
  Adjustments to reconcile net income to cash
    provided by operating activities:
    Depreciation and amortization                         1,119          872

    Changes in assets and liabilities:
      Decrease (increase) in accounts receivable            467       (1,601)
      Decrease (increase) in inventories                    392       (1,346)
      Increase in other assets                               50           41
      Decrease in accounts payable                       (1,190)         (33)
      Increase in receivable
        from Parent                                         391        2,058
      Increase (decrease) in accrued liabilities          1,009          (12)
                                                     -----------  -----------
        Cash flows provided by operating activities       6,647        3,427
                                                     -----------  -----------

Cash flows from investing activities:
  Purchase of property, plant and equipment              (1,121)      (1,139)
  Net cash used in the acquisition of
    PSI-Tronix, Inc.                                     (8,703)          --
  Acquisition of Lundahl Instruments, net
    of cash                                                  --       (2,659)
  Sale of short-term investments                          1,429          766
                                                     -----------  -----------
        Cash flows used in investing activities          (8,395)      (3,032)
                                                     -----------  -----------

Cash flows from financing activities:
  Dividends                                              (1,449)      (1,315)
  Issuance (repurchase) of common stock                      19         (206)
                                                     -----------  -----------
        Cash flows used in financing activities          (1,430)      (1,521)
                                                     -----------  -----------
Change in cash and cash equivalents                      (3,178)      (1,126)

Cash and cash equivalents at beginning of period          3,362        2,577
                                                     -----------  -----------
Cash and cash equivalents at end of period          $       184  $     1,451
                                                     ===========  ===========

Supplemental disclosure of cash flow information:
  Cash paid to the Parent for income taxes          $     2,702  $     2,113
                                                     ===========  ===========`

The accompanying notes are an integral part of these financial statements.

---

**SCIENTIFIC TECHNOLOGIES INCORPORATED

               NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

The consolidated financial statements as of September
30, 2000, for the three and nine months ended September 30, 2000 and for the
three and nine months ended September 30, 1999 are unaudited. In the opinion of
management, they reflect all adjustments (consisting only of normal recurring
adjustments) necessary for a fair statement of the results of these periods but
may not necessarily be indicative of the results to be expected for the full
fiscal year. Certain information and footnote disclosures normally included in
financial statements prepared in accordance with generally accepted accounting
principles have been consolidated or omitted pursuant to the rules and
regulations of the Securities and Exchange Commission. We suggest that these
consolidated financial statements be read in conjunction with the financial
statements and notes thereto included in Scientific Technologies Incorporated's
Annual Report to Shareholders on Form 10-K for the year ended December 31,
1999.

1. INVENTORIES

Inventories consisted of the following:	       	(In
thousands)

`September 30,  December 31,
                                           2000           1999
                                       -------------  -------------
    Raw materials                     $       3,592  $       4,095
    Subassemblies                               862            948
    Work in process                             438            263
    Finished goods                            3,694          3,108
                                       -------------  -------------
                                      $       8,586  $       8,414
                                       =============  =============`

2. NET INCOME PER SHARE

A reconciliation of the numerators and denominators of the
basic and diluted income per common share computations is provided below.

`Per
                                            (In thousands)      Share
                                           Income    Shares    Amount
                                          --------- ---------  -------
Three months ended September 30, 2000
----------------------------------------
Basic earnings per share calculation     $   1,604     9,637  $  0.17
Effect of dilutive securities
    Stock options                               --        96       --
                                          --------- ---------  -------
Diluted earnings per share calculation   $   1,604     9,733  $  0.17
                                          ========= =========  =======
Three months ended September 30, 1999
----------------------------------------
Basic earnings per share calculation     $   1,305     9,667  $  0.14
Effect of dilutive securities
    Stock options                               --        25       --
                                          --------- ---------  -------
Diluted earnings per share calculation   $   1,305     9,692  $  0.14
                                          ========= =========  =======
Nine months ended September 30, 2000
----------------------------------------
Basic earnings per share calculation     $   4,409     9,640  $  0.46
Effect of dilutive securities
    Stock options                               --        27       --
                                          --------- ---------  -------
Diluted earnings per share calculation   $   4,409     9,667  $  0.46
                                          ========= =========  =======
Nine months ended September 30, 1999
----------------------------------------
Basic earnings per share calculation     $   3,448     9,652  $  0.36
Effect of dilutive securities
    Stock options                               --        26       --
                                          --------- ---------  -------
Diluted earnings per share calculation   $   3,448     9,678  $  0.36
                                          ========= =========  =======`

3. DIVIDEND PAID

On September 1, 2000, the Company paid a
cash dividend of $.05 per share on all outstanding shares of its common stock to
shareholders of record on August 18, 2000. Dividends of $.05 per share on all
outstanding shares of common stock were paid on July 5, 2000 to shareholders of
record on June 23, 2000, and April 3, 2000 to shareholders of record on March
17, 2000. Approximately 87% of the outstanding common stock of the Company is
beneficially owned by Scientific Technology Incorporated, a California
corporation under common control with the Company. Dividends paid to Scientific
Technology Incorporated were applied to the Payable to Parent account.



4. COMPREHENSIVE INCOME

For the three months ended September 30,
2000 and 1999, there is no difference between net income and comprehensive
income.

5. RECENT ACCOUNTING PRONOUNCEMENTS

In June 1998, the Financial Accounting Standards
Board ("FASB") issued Statement of Financial Accounting Standards No. 133 ("SFAS
133"), "Accounting for Derivative Instruments and Hedging Activities," which
establishes accounting and reporting standards for derivative instruments and
for hedging activities. It requires that an entity recognize all derivatives as
either assets or liabilities in the balance sheet and measure those instruments
at fair value. Management does not expect the adoption of SFAS 133 to have a
material effect on the Company's operations or financial position. The Company
is required to adopt SFAS 133 in the first quarter of fiscal 2001.

In December 1999, the SEC issued Staff Accounting Bulletin
No. 101 ("SAB 101"), "Revenue Recognition in Financial Statements." SAB 101
summarizes certain of the SEC's views in applying generally accepted accounting
principles to revenue recognition in financial statements. Management does not
expect the adoption of SAB 101 to have a material effect on the Company's
operations or financial position. The Company is required to adopt SAB 101 in
the fourth quarter of fiscal 2000 and will do so in that period.

6. ACQUISITION OF PSI-TRONIX, INC.

(Amounts in thousands)

On March 16, 2000, the Company acquired
substantially all of the assets and liabilities of PSI-Tronix, Inc. ("PSI-
Tronix") for a cash purchase price of $8,703. Of the total purchase price,
$4,222 was allocated to goodwill, $1,500 was allocated to technology and $1,101
was allocated to customer lists. The Company is generally amortizing the
intangible assets it acquired in the transaction using the straight-line method
over five to twenty years. The transaction was accounted for using the purchase
method of accounting. The operations and financial position of PSI-Tronix were
accounted for in the consolidated financial statements of the Company beginning
in March 2000. PSI-Tronix designs, develops and manufactures pressure
transducers, digital pressure gauges, displacement and velocity transducers, and
pressure comparators, for use in a variety of factory, aerospace, medical and
semiconductor oil and gas markets and applications. Additional information for
this acquisition is included in the Company's amended Form 8K/A, filed on May
30, 2000.



The following unaudited pro-forma consolidated
amounts give effect to this acquisition as if it had occurred on January 1, 1999
by consolidating the results of operations of PSI-Tronix with the results of the
Company for the nine months ended September 30, 2000 and 1999.

`2000           1999
                                       -------------  -------------
    Sales                             $      45,231  $      42,081
                                       =============  =============

    Net income                        $       4,727  $       4,486
                                       =============  =============

    Net income per common share,
      basic and diluted               $        0.49  $        0.46
                                       =============  =============
    Shares used to compute net
      income per common share:
         Basic                                9,640          9,652
                                       =============  =============
         Diluted                              9,667          9,678
                                       =============  =============`



ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS



This interim report on Form 10-Q contains trend
analysis and other forward-looking statements within the meaning of Section 27A
of the Securities Act of 1933 and Section 21E of the Securities Act of 1934.
Such statements include expectations, beliefs, intentions or strategies
regarding future operating results, future expenditures, future cash
requirements, and future industry conditions that involve risks and
uncertainties. The Company's actual results could differ materially from those
projected in such forward-looking statements as a result of many factors,
including, without limitation, those set forth under this section, the section
entitled "Business Factors" below and elsewhere in this report on Form 10-Q.



Results of Operations

(Amounts in thousands except percentages)



Scientific Technologies Incorporated designs,
manufactures and distributes automation safeguarding and specialty sensor
products for the industrial control market. The Company's products include
safety light guards, profiling scanners, factory automation sensors, controls,
components, microcomputers, fiber optics, power monitoring devices, safety mats,
pressure, displacement and velocity transducers, digital pressure gauges and
comparators and other electronic equipment supplied to industrial automation,
commercial and defense customers.



Sales for the three months ended September 30,
2000 increased 17% to $14,992 from $12,804 in the third quarter of 1999. For the
nine months ended September 30, 2000 sales increased 20% to $43,691 from $36,378
in the comparable period in 1999. Third quarter and nine-month sales were
positively impacted by the acquisition of PSI-Tronix in March 2000, by the
growth of the Company's automation safety products, and to a lesser extent, by
the effect of increased pricing of certain the Company's safety products and
sensors.



Gross margin as a percentage of sales was 50%
during the third quarter of 2000 and 1999 Gross margin for the nine-month period
ended September 30, 2000 was 52% of sales compared to 50% for the same period in
1999. This was primarily the result of economies of scale associated with the
higher sales levels and price increases mentioned above, and of a shift in the
mix of sales to products with a relatively lower cost of sales.



Selling, general and administrative expenses
increased 17% to $3,776 in the third quarter of 2000 from $3,231 in the third
quarter of 1999. For the nine months ended September 30, 2000, selling general
and administrative expenses rose 22% to $11,682 from $9,545 in the comparable
1999 period. These increases were due to expenses incurred by the PSI-Tronix
business the Company acquired, as well as higher expenses associated with the
increased levels of revenue. Selling, general and administrative expenses
remained constant at 25% of sales for the three months ended September 30, 2000
and 1999 and increased to 27% of sales in the nine months ended September 30,
2000 compared to 26% in the same 1999 period, again primarily the result of PSI-
Tronix related expenses.



Reflecting the Company's continuing commitment
to new product development, third quarter 2000 research and development expenses
increased 2% to $1,195 from $1,169 in the comparable period in 1999. For the
nine months ended September 30, 2000, research and development expenses grew 13%
to $3,920 from $3,465 in the first nine months of 1999. Research and development
expenses were 8% of sales for the three months ended September 30, 2000 compared
to 9% for the comparable 1999 quarter. Research and development expenses were 9%
for the first nine months of 2000 compared to 10% of sales for the first nine
months of 1999. The Company anticipates that it will continue to make
substantial investments in research and development in future quarters.





Liquidity and Capital Resources



At September 30, 2000 the Company's working
capital was $18,388, a 19% reduction from the $22,712 reported at December 31,
1999. This decline was primarily the result of the acquisition of PSI-Tronix in
March of 2000, reduced short-term investments, increased accrued expenses and an
increase to Payable to Parent account, which reduction was partially offset by
positive cash flows from operations resulting in higher accounts receivable and
inventories and a lower accounts payable.



Available bank borrowings were $6,100,000, all of
which were unused at September 30, 2000. The Company believes that cash from
operations, together with its cash resources and available bank borrowings, will
be sufficient to fund its working capital requirements for the next twelve
months.



Business Factors



Because of the variety of factors and
uncertainties affecting the Company's operating results, past financial
performance and historic trends may not be a reliable indicator of future
performance. These factors, as well as other factors affecting the Company's
operating performance, may result in significant volatility in the Company's
common stock price. Among the factors which could affect future results are:



Variability of operating results

The Company has experienced fluctuations in annual
and quarterly operating results and anticipates that these fluctuations will
continue in the foreseeable future. These fluctuations are caused by a number of
factors, including the level and timing of customer orders, the mix of products
sold, fluctuations in sales of complementary third party products with which STI
products are sold, the timing of operating expenditures and general economic
conditions in the U.S. and abroad, particularly in Asia and Europe.



Sources and availability of components

The Company maintains an inventory of components
and parts for its manufacturing activities. There are many sources for most of
the components needed; however STI purchases some products, components and sub-
assemblies from sole sources, which may be the only available supplier or may
enable the Company to obtain pricing or supply efficiencies. In the event of
supply interruptions from these vendors, the Company believes it could obtain
most of these sole source components from alternate suppliers, but this would
require the Company to transfer tooling or designs or redesign its products to
facilitate use of alternate-source components. STI could incur delays in
production by switching to an alternate source, which could have an adverse
effect on the its business, financial condition and results of operations.



Seasonality

The industrial manufacturing equipment industry can
be subject to seasonality. This is also true with respect to European markets
where business activity typically declines due to vacations taken in the summer
months. This seasonality could adversely affect our operating results, which
could cause our stock price to decline.



Competition

The market for industrial sensors is highly
competitive. Many of the Company's competitors have substantially greater name
recognition and technical, marketing and financial resources than the Company.
Competitive pressures could reduce market acceptance of the Company's products
and result in price reductions and increases in expenses.



Rapid technological change and new product
development

The Company's future success will depend on its
ability to enhance its current products, develop new products and respond to
emerging industry standards, all on a timely and cost-effective basis. The
Company cannot assure you that it will continue to be able to timely develop
products and product enhancements that meet the rapid evolving needs of its
customers. The introduction of new products also requires the Company to devote
substantial resources in order to manage the transition from older products in
order to minimize disruption of customer orders, avoid excessive levels of older
product inventories and ensure that adequate supplies of new products can be
delivered to meet customer demands. The Company may be unable to generate
significant revenue to offset any new product related expenditures, which would
adversely affect the Company's operating results.



Dependence on indirect distribution channel

A majority of the Company's products are sold through
third party distributors, systems integrators and original equipment
manufacturers. These resellers are not required to offer the Company's products
exclusively and there can be no assurance that any of the Company's resellers
will continue to offer the Company's products.



International sales

The Company's international sales may be disrupted by
currency fluctuations or other international events beyond the Company's
control, including political or regulatory changes and changes in general
economic conditions.



Protection and Enforcement of Intellectual Property
Rights

The Company relies on a combination of patent,
trademark and trade secret laws and contractual restrictions to establish and
protect certain proprietary rights in its products and services. There can be no
assurance that the Company's patents, trademarks, or contractual arrangements or
other steps taken by the Company to protect its intellectual property will prove
sufficient to prevent misappropriation of the Company's technology or defer
independent third party development of similar technologies. Moreover, there can
be no assurance that the technology licenses granted to the Company from its
Parent will continue to be available on satisfactory terms or at all. The loss
of any of the Company's proprietary technology could require the Company to
obtain technology of lower quality or performance standards or at greater cost,
which could materially adversely affect the Company's business, results of
operations and financial condition. Furthermore, the laws of certain foreign
countries may not protect the Company's products, services or intellectual
property rights to the same extent as do the laws of the United States.

Risks Associated with Potential Acquisitions,
Investments or Other Ventures

The Company may acquire or make investments in
complementary businesses, technologies, services or products if appropriate
opportunities arise. From time to time, the Company has discussions and
negotiations with other companies regarding acquiring or investing in such
companies' businesses, products, services or technologies, and the Company
regularly engages in such discussions and negotiations in the ordinary course of
its business. For example, on March 16, 2000, the Company completed the
acquisition of substantially all of the assets and liabilities of PSI-Tronix,
Inc. There can be no assurance that the Company will be able to identify future
suitable acquisition or investment candidates, or if it does identify suitable
candidates, that it will be able to make such acquisitions or investments on
commercially acceptable terms or at all. If the Company acquires or invests in
another company, it could have difficulty in assimilating that company's
personnel, operations, technology and software or integrating the acquired
products, services or technologies in its operations. Further, any such
acquisition could cause the Company to assume unanticipated liabilities of the
acquired company. In addition, the key personnel of the acquired company may
decide not to work for the Company. These difficulties could disrupt the
Company's ongoing business, distract its management and employees, increase its
expenses and adversely affect its result of operations. Furthermore, the Company
may incur indebtedness or issue equity securities to pay for any future
acquisitions. The issuance of equity securities would be dilutive to the
Company's existing shareholders.



PART II - OTHER INFORMATION



Items 1 - 4 and 5 are not applicable for this reporting
period.





Item 6. EXHIBITS AND REPORTS ON FORM 8-K.

(a)  The following documents are filed as a part of this Report:





|**Exhibit Number** | **Description**                                                                                                                                                                                                                     
|------------------ | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Exhibit  3.1 -     | Articles of Incorporation, as amended, are incorporated by reference to the
   Registrant's Form 10-K for the year ended December 31, 1988, Exhibit 3.1.                                                                            
|Exhibit  3.3 -     | By-Laws are incorporated by reference to the Registrant's Form 10-K for
          the year ended December 31, 1985, Exhibit 3.                                                                                                      
|Exhibit  4.1 -     | 1997 Employee Stock Purchase Plan is incorporated by reference to the
          Registrant's Registration Statement on Form S-8 dated October 2, 1998.                                                                              
|Exhibit  4.2 -     | 1997 Stock Plan is incorporated by reference to the Registrant's
   Registration Statement on Form S-8 dated October 2, 1998.                                                                                                       
|Exhibit  10.1 -    | Lease agreement dated February 21, 1995 for 6550 Dumbarton Circle,
           Fremont, California 94555, is incorporated by reference to the Registrant's
           Form 10-KSB for the year ended December 31, 1994, Exhibit 10.4.
|Exhibit  10.2 -    | Bank agreement dated November 29, 1994 with Bank of The West is
           incorporated by reference to the Registrant's Form 10-KSB for the year
           ended December 31, 1994, Exhibit 10.3.                                 
|Exhibit  10.3 -    | Amendment dated May 31, 1999 to Bank Agreement dated November 29,
           1994 is incorporated by reference to the Registrant's Form 10-K for
the year ended December 31, 1999, Exhibit 10.3.                                    
|Exhibit  10.4 -    | Lease agreement dated November 21, 1995  is incorporated by reference
           to the Registrant's Form 10-KSB for the year ended December 31, 1995,
           Exhibit 10.4.                                                     
|Exhibit  10.5 -    | Agreement dated January 1, 1997 with Scientific Technology Inc. for the
           purchase of the level sensor product line.                                                                                                       
|Exhibit  21.1 -    | Subsidiaries of the Registrant  is incorporated by reference to the
           Registrant's Form 10-K for the year ended December 31, 1999,
           Exhibit 21.1.                                                                
|Exhibit  23.1 -    | Consent of Independent Accountants is incorporated by
reference to  the Registrant's Form 10-K for the year ended December 31,
1999,  Exhibit 23.1.                                                                                 
|Exhibit  24.1 -    | Power of Attorney is incorporated by reference to the Registrant's Form
10-K  for the year ended December 31, 1999, Exhibit 24.1.                                                                                                   
|Exhibit  27.0 -    | Financial Data Schedule.                                                                                                                                                                                                            

(b)  No reports on Form 8-K were filed during the third quarter of 2000.

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.



| |                                     
| | ------------------------------------
| | SCIENTIFIC TECHNOLOGIES INCORPORATED

| |             
| | ------------
| | (Registrant)

Date: November 13, 2000



| |     |                     
| | --- | --------------------
| | By: | /s/Joseph J. Lazzara

| |                                                                                  
| | ---------------------------------------------------------------------------------
| |                                                                                  
| | Joseph J. Lazzara                                                                
| | President and Chief Executive Officer
(Principal Executive and Financial officer)

Date: November 13, 2000



| |     |                     
| | --- | --------------------
| | By: | /s/ Richard O. Faria

| |                                                                        
| | -----------------------------------------------------------------------
| |                                                                        
| | Richard O. Faria                                                       
| | Vice-President, Finance & Administration
(Principal Accounting Officer)

---